Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water

Toxicological Sciences

Volumn 104, Issue 1, 2008, Pages 40-53

  Chang, Shu Ching ^a   Das, Kaberi ^b   Ehresman, David J ^a   Ellefson, Mark E ^a   Gorman, Gregory S ^c   Hart, Jill A ^a   Noker, Patricia E ^c   Tan, Yu Mei ^d   Lieder, Paul H ^a   Lau, Christopher ^b   Olsen, Geary W ^a   Butenhoff, John L ^a  

^a 3M COMPANY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

Author keywords

Biomonitoring; Perfluorobutyrate; PFBA; Pharmacokinetics

Indexed keywords

AMMONIA; DRINKING WATER; PERFLUORO COMPOUND; PERFLUOROBUTYRIC ACID;

ADULT; AGED; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG ELIMINATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH HAZARD; HUMAN; INDUSTRIAL WORKER; MALE; MONKEY; MOUSE; NONHUMAN; RAT; RISK ASSESSMENT; TOXICOLOGY; WORKPLACE;

ANIMALS; ENVIRONMENTAL MONITORING; FECES; FEMALE; FLUOROCARBONS; HAPLORHINI; HUMANS; LIVER; MACACA FASCICULARIS; MALE; MICE; OCCUPATIONAL EXPOSURE; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

MUS; RATTUS;

EID: 45549089605     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn057     Document Type: Article

References (33)

1. Andersen, M. E., Clewell, H. J., 3rd., Tan, Y. M., Butenhoff, J. L., and Olsen, G. W. (2006). Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-lives. Toxicology 227, 156-164.
2. Bondy, G. S., Curran, I., Coady, L., Armstrong, C., Parenteau, M., Liston, V., Hierlihy, L., and Shenton, J. (2006). Immunomodulation by perfluorooctanesulfonate (PFOS) in a 28-day rat feeding study. The Toxicologist 90, 21.
3. Butenhoff, J. L., Kennedy, G. L., Jr., Hinderliter, P. M., Lieder, P. H., Jung, R., Hansen, K. J., Gorman, G. S., Noker, P. E., and Thomford, P. J. (2004). Pharmacokinetics d perfluorooctanoate in cynomolgus monkeys. Toxicol. Sci. 82, 394-406.
4. Calafat, A. M., Kuklenyik, Z., Reidy, J. A., Caudill, S. P., Tully, J. S., and Needham L. L. (2007a). Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: Data from the national health and nutrition examination survey (NHANES). Environ. Sci. Technol. 41, 2237-2242.
5. Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A., and Needham, L. L. (2007b). Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 115, 1596- 1602; doi:10.1289/ehp.10598.
6. Castagna, M. (1965). Blood content of rat liver homogenates. Nature 205, 905-907.
7. D'Eon, J. C., Hurley, M. D., Wallington, T. J., and Mabury, S. A. (2006). Atmospheric chemistry of N-methyl perfluorobutane sulfonamidoethanol, C4F9SO2N(CH3)CH2CH2OH: Kinetics and mechanism of reaction with OH. Environ. Sci. Technol. 40, 1862-1868.
8. D'Eon, J. C., and Mabury, S. A. (2007). Production of perfluorinated carboxylic acids (PFCAs) from the biotransformation of polyfluoroalkyl phosphate surfactants (PAPS): Exploring routes of human contamination. Environ. Sci. Technol. 41, 4799-4805.
9. Ehresman, D. J., Froehlich, J. W., Olsen, G. W., Chang, S. C., and Butentroff, J. L. (2007). Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 103, 176-184.
10. Hundley, S. G., Sarrif, A. M., and Kennedy, G. L. (2006). Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem. Toxicol. 29 137-145.
11. Ikeda, T., Aiba, K., Fukuda, K., and Tanaka, M. (1985). The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. 98 475-482.
12. ILAR (1996). Guide for the Care and Use of Laboratory Animals. National Research Council, Institute of Laboratory Animal Resources. National Academy Press, Washington, DC.
13. Intrasuksri, U., and Feller, D. R. (1991). Comparison of the effects of selected monocarboxylic, dicarboxylic and perfluormated fatty acids on peroxisome proliferation in primary cultured rat hepatocytes. Biochem. Pharmacol. 42, 184-188.
14. Intrasuksri, U., Rangwala, S. M., O'Brien, M., Noonan, D. J., and Feller, D. R. (1998). Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. Gen. Pharmacol. 31, 187-197.
15. Just, W. W., Gorgas, K., Hartl, F. U., Heinemann, P., Salzer, M., and Schimassek, H. (1989). Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver. Hepatology 9, 570-581.
16. Katakura, M., Kudo, N., Tsuda, T., Hibino, Y., Mitsumoto, A., and Kawashima, Y. (2007). Rat organic anion transporter 3 and organic anion transporting polypeptide 1 mediate perfluorooctanoic acid transport. J. Health Sci. 53, 77-83.
17. Kennedy, G. L., Jr., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. (2004). The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34, 351-384.
18. Kozuka, H., Watanabe, T., Horie, S., Yamada, J., Suga, T., and Ikeda, T. (1991a). Characteristics of peroxisome proliferation: Co-induction of peroxisomal fatty acid oxidation-related enzymes with microsomal laurate hydroxylase. Chem. Pharm. Bull. (Tokyo) 39, 1267-1271.
19. Kozuka, H., Yamada, J., Horie, S., Watanabe, T., Suga, T., and Ikeda, T. (1991b). Characteristics of induction of peroxisomal fatty acid oxidation-related enzymes in rat liver by drugs. Relationships between structure and inducing activity. Biochem. Pharmacol. 41, 617-623.
20. Kudo, N., and Kawashima, Y. (2003). Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28, 49-57.
21. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. (2007). Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99, 366- 394; doi:10.1093/toxsci/kfm128.
22. Martin, J. W., Ellis, D. A., Mabury, S. A., Hurley, M. D., and Wallington, T. J. (2006). Atmospheric chemistry of perfluoroalkanesulfonamides: Kinetic and product studies of the OH radical and CI atom initiated oxidation of N-ethyl perfluorobutanesulfonamide. Environ. Sci. Technol. 40, 864-872.
23. Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., and Zobel, L. R. (2007a). Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115, 1298- 1305; doi:10.1289/ ehp.10009.
24. Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, J. K., Armitage, J. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., et al. (2003). Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111, 1892-1901.
25. Olsen, G. W., Mair, D. C., Reagen, W. K., Ellefson, M. E., Ehresman, D. J., Butenhoff, J. L., and Zobel, L. R. (2007b). Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 68, 105-111.
26. Permadi, H., Lundgren, B., Andersson, K., and DePierre, J. W. (1092). Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem. Pharmacol. 44, 1183-1191.
27. Permadi, H., Lundgren, B., Andersson, K., Sundberg, C., and DePierre, J. W. (1993). Effects of perfluoro fatty acids on peroxisome proliferation and mitochondrial size in mouse liver: Dose and time factors and effect of chain length. Xenobiotica 23, 761-770.
28. Scott, B. F., Moody, C. A., Spencer, C., Small, J. M., Muir, D. C., and Mabury, S. A. (2006a). Analysis for perfluorocarboxylic acids/anions in surface waters and precipitation using GC-MS and analysis of PFOA from large-volume samples. Environ. Sci. Technol. 40, 6405-6410.
29. Scott, B. F., Spencer, C., Mabury, S. A., and Muir, D. C. (2006b). Poly and perfluorinated carboxylates in North American precipitation. Environ. Sci. Technol. 40, 7167-7174.
30. Skutlarek, D., Exner, M., and Farber, H. (2006). Perfluorinated surfactants in surface and drinking waters. Environ. Sci. Pollut. Res. Int. 13, 299-307.
31. Takagi, A., Sai, K., Umemura, T., Hasegawa, R., and Kurokawa, Y. (1991). Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett. 57 55-60.
32. Vanden Heuvel, J. P., Kuslikis, B. I., Shrago, E., and Petersdn, R. E. (1991). Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes. Biochem. Pharmacol. 42, 295-302.
33. Wagner, J. W. (1975). Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Press, Hamilton, IL.